| 000 | 01036 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516165534.0 | ||
| 264 | 0 | _c20140514 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdt296 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeo, M | |
| 245 | 0 | 0 |
_aRole of second-line chemotherapy in advanced pancreatic cancer and its influence on phase II/III study results. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2013 |
||
| 300 |
_a2462-3 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 700 | 1 | _aMcDermott, R S | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 24 _gno. 9 _gp. 2462-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdt296 _zAvailable from publisher's website |
| 999 |
_c23042377 _d23042377 |
||